Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Cytotoxic Effect on HepG2 Cell Line and In Vitro, In Silico Evaluation of 1,2,4-Triazine Compounds as Inhibitors of Acetylcholinesterase and Glutathione S-Transferase. | J Biochem Mol Toxicol | 2025 | 40702843 | PubTator, text mining | PubMed |
| A predictive serum miRNA signature impacts diffuse large B-cell lymphoma cell viability via inhibition of EGLN1 and TXNRD1 regulators of ferroptosis. | Br J Haematol | 2025 | 40685776 | PubTator, text mining | PubMed |
| Heterogeneous expression of long noncoding RNA RP11-109D20.2: Insights into regulatory gene expression roles in colon cancer. | Iran J Basic Med Sci | 2025 | 40666182 | PubTator, text mining | PubMed |
| Modification and applications of glucose oxidase: optimization strategies and high-throughput screening technologies. | World J Microbiol Biotechnol | 2025 | 40650823 | PubTator, text mining | PubMed |
| Mutational analysis of TXNRD1 reveals the essential role of Trp114 in TRP14 reduction and identifies key determinants of enzymatic activity and thermostability. | Free Radic Biol Med | 2025 | 40639632 | PubTator, text mining | PubMed |
| Identification and validation of MMP1 as a biomarker associated with mitochondrial oxidative stress in liver hepatocellular carcinoma. | Sci Rep | 2025 | 40624187 | PubTator, text mining | PubMed |
| Effect of Imidazole Derivatives on U-87 MG Glioblastoma Cell Lines via TrxR1, GST and GR, Antimicrobial and Antioxidant Activities. | J Biochem Mol Toxicol | 2025 | 40621795 | PubTator, text mining | PubMed |
| Study on the physiological mechanism and molecular regulatory network of Blumea balsamifera in response to drought stress. | BMC Plant Biol | 2025 | 40604416 | PubTator, text mining | PubMed |
| Hydroxytyrosol induced ferroptosis through Nrf2 signaling pathway in colorectal cancer cells. | Sci Rep | 2025 | 40594119 | PubTator, text mining | PubMed |
| Bicyclic Selenenyl Sulfides with Tuned Bioreductive Step Rates Reveal Constraints for Probes Targeting Thioredoxin Reductase. | Angew Chem Int Ed Engl | 2025 | 40583823 | PubTator, text mining | PubMed |
| Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma. | Cancer Biol Med | 2025 | 40579895 | PubTator, text mining | PubMed |
| Ivy Leaf Dry Extract EA 575® Is a Potent Immunomodulator Acting on Dendritic Cells. | Pharmaceutics | 2025 | 40574085 | PubTator, text mining | PubMed |
| Machine-Learning-Assisted Nanozyme-Based Sensor Arrays: Construction, Empowerment, and Applications. | Biosensors (Basel) | 2025 | 40558426 | PubTator, text mining | PubMed |
| [Placental Tissue Transcriptomics as a Tool to Identify the Molecular Mechanisms of Great Obstetrical Syndromes]. | Mol Biol (Mosk) | 2025 | 40558034 | PubTator, text mining | PubMed |
| Novel role of peroxiredoxin 6 in ferroptosis: Bridging selenium transport with enzymatic functions. | Free Radic Biol Med | 2025 | 40543852 | PubTator, text mining | PubMed |
| AKR1C2 silencing promotes ferroptosis and inhibits proliferation, migration, and invasion in lung cancer cells. | PLoS One | 2025 | 40531841 | PubTator, text mining | PubMed |
| The RNF/NQR redox pumps: a versatile system for energy transduction in bacteria and archaea. | Appl Microbiol Biotechnol | 2025 | 40528048 | PubTator, text mining | PubMed |
| Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 40498096 | PubTator, text mining | PubMed |
| Experimental and Computational Evaluation of Nicotinamide Cofactor Biomimetics. | ACS Chem Biol | 2025 | 40490396 | PubTator, text mining | PubMed |
| A dual inhibitor of TrxR1 and XIAP induces pyroptosis in melanoma. | Front Cell Dev Biol | 2025 | 40486906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=13